{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:19:43Z","timestamp":1787242783272,"version":"build-2736575974"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Myasthenia Gravis (MG) is a chronic autoimmune disorder frequently accompanied by anxiety and depression, which aggravate disease burden. Evidence on the relationship between clinical characteristics and psychological symptoms in MG remains inconsistent.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a cross-sectional study of 93 Chinese MG patients. Clinical and demographic data were collected, and anxiety and depression were assessed using the Hospital Anxiety and Depression Scale (HADS). Associations were examined by correlation, chi-square tests, and logistic regression with false discovery rate (FDR) correction. Multivariable models adjusted for age and sex. ROC curve analyses evaluated the predictive performance of (MG Activities of Daily Living) MG-ADL, (15-item Myasthenia Gravis Quality of Life scale) MG-QOL-15, and (Social Support Rating Scale) SSRS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Anxiety and depression were present in 30.1 and 35.5% of patients, respectively. In multivariable analysis, reduced quality of life (MG-QOL-15, OR\u202f=\u202f0.85, 95% CI: 0.78\u20130.92,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001) and insufficient social support (SSRS, OR\u202f=\u202f1.08, 95% CI: 1.00\u20131.16,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.03) independently predicted psychological distress, whereas MGFA classification was not significant. Supplementary linear regression confirmed these findings. ROC analysis showed MG-QOL-15 had the best performance in detecting both anxiety (AUC\u202f=\u202f0.884) and depression (AUC\u202f=\u202f0.837), while SSRS had moderate value and MG-ADL limited discrimination.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Psychological distress in MG is more closely linked to quality of life and social support than to conventional disease severity. Routine psychological screening with MG-QOL-15 and SSRS may facilitate early identification of high-risk patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2025.1670436","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T06:31:12Z","timestamp":1762929072000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Quality of life and social support as key determinants of anxiety and depression in Myasthenia Gravis: evidence from a Chinese cohort"],"prefix":"10.3389","volume":"16","author":[{"given":"Xiang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengbin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinfeng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.25122\/jml-2020-0145","article-title":"The epidemiology of myasthenia gravis","volume":"14","author":"Bubuioc","year":"2021","journal-title":"J Med Life"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S1474-4422(21)00297-0","article-title":"Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders","volume":"21","author":"Punga","year":"2022","journal-title":"Lancet Neurol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","article-title":"International consensus guidance for management of myasthenia gravis: executive summary","volume":"87","author":"Sanders","year":"2016","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10072-020-04528-w","article-title":"Social, professional and neuropsychiatric outcomes in patients with myasthenia gravis","volume":"42","author":"Vitturi","year":"2021","journal-title":"Neurol Sci"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"470","DOI":"10.5498\/wjp.v12.i3.470","article-title":"Studying the relationship between clinical features and mental health among late-onset myasthenia gravis patients","volume":"12","author":"Yu","year":"2022","journal-title":"World J Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10072-006-0606-y","article-title":"Validation of the Swedish version of the disease-specific myasthenia gravis questionnaire","volume":"27","author":"Rostedt","year":"2006","journal-title":"Neurol Sci"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e2840","DOI":"10.1002\/brb3.2840","article-title":"Prevalence of depression and anxiety among myasthenia gravis (MG) patients: a systematic review and meta-analysis","volume":"13","author":"Nadali","year":"2023","journal-title":"Brain Behav"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s12325-023-02704-w","article-title":"The burden patients with myasthenia gravis experience in terms of breathing, fatigue, sleep, mental health, discomfort and usual activities in comparison to the general population","volume":"41","author":"Dewilde","year":"2024","journal-title":"Adv Ther"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"295","DOI":"10.4274\/npa.y5611","article-title":"The relationship of symptoms of anxiety and depression with disease severity and treatment modality in myasthenia gravis: a cross-sectional study","volume":"50","author":"Aysal","year":"2013","journal-title":"Noro Psikiyatr Ars"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"19275","DOI":"10.1038\/s41598-022-22078-3","article-title":"Mental health in myasthenia gravis patients and its impact on caregiver burden","volume":"12","author":"Marbin","year":"2022","journal-title":"Sci Rep"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.3390\/brainsci13091286","article-title":"Diagnosis and management of seronegative myasthenia gravis: lights and shadows","volume":"13","author":"Vinciguerra","year":"2023","journal-title":"Brain Sci"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"111793","DOI":"10.1016\/j.mad.2023.111793","article-title":"Sex differences in neuromuscular disorders","volume":"211","author":"Vinciguerra","year":"2023","journal-title":"Mech Ageing Dev"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3969\/j.issn.1006-2963.2021.01.001","article-title":"Chinese guidelines for the diagnosis and treatment of myasthenia gravis (2020 edition)","volume":"28","author":"Chang","year":"2021","journal-title":"Chin J Neuroimmunol Neurol"},{"key":"ref16","first-page":"16","article-title":"Myasthenia gravis: recommendations for clinical research standards","volume-title":"Neurology","author":"Jaretzki","year":"2000"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1111\/ene.13867","article-title":"Sensitivity of MG-ADL for generalized weakness in myasthenia gravis","volume":"26","author":"de Meel","year":"2019","journal-title":"Eur J Neurol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jphys.2018.04.003","article-title":"Clinimetrics: hospital anxiety and depression scale","volume":"64","author":"Beekman","year":"2018","journal-title":"J Physiother"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"3921","DOI":"10.1007\/s00520-019-05244-8","article-title":"Hospital anxiety and depression scale (HADS) accuracy in cancer patients","volume":"28","author":"Annunziata","year":"2020","journal-title":"Support Care Cancer"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12955-017-0759-9","article-title":"Is the hospital anxiety and depression scale (HADS) a valid measure in a general population 65-80 years old? A psychometric evaluation study","volume":"15","author":"Djukanovic","year":"2017","journal-title":"Health Qual Life Outcomes"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.genhosppsych.2021.01.014","article-title":"Validity of the hospital anxiety and depression scale (HADS) in primary care patients in Colombia","volume":"74","author":"Cassiani-Miranda","year":"2022","journal-title":"Gen Hosp Psychiatry"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/s0022-3999(01)00296-3","article-title":"The validity of the hospital anxiety and depression scale. An updated literature review","volume":"52","author":"Bjelland","year":"2002","journal-title":"J Psychosom Res"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12913-016-1423-5","article-title":"The theoretical basis and research application of \u201csocial support rating scale\u201d","volume":"2","author":"Xiao","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12889-016-2871-x","article-title":"Association between social support and recovery from post-traumatic stress disorder after flood: a 13\u201314-year follow-up study in Hunan, China","volume":"16","author":"Dai","year":"2016","journal-title":"BMC Public Health"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/mus.21883","article-title":"The MG-QOL15 for following the health-related quality of life of patients with myasthenia gravis","volume":"43","author":"Burns","year":"2011","journal-title":"Muscle Nerve"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1097\/JTO.0b013e3181ec173d","article-title":"Receiver operating characteristic curve in diagnostic test assessment","volume":"5","author":"Mandrekar","year":"2010","journal-title":"J Thorac Oncol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3389\/fpsyt.2019.00131","article-title":"Autoimmune diseases and psychotic disorders","volume":"10","author":"Jeppesen","year":"2019","journal-title":"Front Psych"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"120268","DOI":"10.1016\/j.jns.2022.120268","article-title":"The humanistic burden of myasthenia gravis: a systematic literature review","volume":"437","author":"Gelinas","year":"2022","journal-title":"J Neurol Sci"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1111\/ppc.12760","article-title":"Perceived social support, mental health, and marital satisfaction in multiple sclerosis patients","volume":"57","author":"\u00d6zen","year":"2021","journal-title":"Perspect Psychiatr Care"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.1007\/s10072-025-08218-3","article-title":"Pro-inflammatory cytokines in myasthenia gravis: a systematic review and meta-analysis","volume":"46","author":"Shushtari","year":"2025","journal-title":"Neurol Sci"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"CD011711","DOI":"10.1002\/14651858.CD011711.pub2","article-title":"Respiratory muscle training in children and adults with neuromuscular disease","volume":"9","author":"Silva","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"931","DOI":"10.3390\/biology14080931","article-title":"Hypoxia disrupted serotonin levels in the prefrontal cortex and striatum, leading to depression-like behavior","volume":"14","author":"\u00c7al\u0131\u015fkan","year":"2025","journal-title":"Biology"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3390\/brainsci13020170","article-title":"Frequency and correlates of mild cognitive impairment in myasthenia gravis","volume":"13","author":"Iacono","year":"2023","journal-title":"Brain Sci"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neuroscience.2024.02.021","article-title":"Neurometabolic and brain functional alterations associated with cognitive impairment in patients with myasthenia gravis: a combined 1H-MRS and fMRI study","volume":"544","author":"Zhou","year":"2024","journal-title":"Neuroscience"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"6114","DOI":"10.1007\/s00415-024-12569-w","article-title":"United States clinical practice experience with eculizumab in myasthenia gravis: symptoms, function, and immunosuppressant therapy use","volume":"271","author":"Habib","year":"2024","journal-title":"J Neurol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1756286420911784","DOI":"10.1177\/1756286420911784","article-title":"Response to eculizumab in patients with myasthenia gravis recently treated with chronic IVIg: a subgroup analysis of REGAIN and its open-label extension study","volume":"13","author":"Jacob","year":"2020","journal-title":"Ther Adv Neurol Disord"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s13760-016-0689-z","article-title":"A comparison between IVIG and plasma exchange as preparations before thymectomy in myasthenia gravis patients","volume":"117","author":"Alipour-Faz","year":"2017","journal-title":"Acta Neurol Belg"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"973954","DOI":"10.3389\/fsurg.2022.973954","article-title":"Neurological outcomes of extended thymectomy for thymomatous myasthenia gravis: subxiphoid vs. trans-sternal approaches","volume":"9","author":"Zhu","year":"2022","journal-title":"Front Surg"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1670436\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T06:31:14Z","timestamp":1762929074000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1670436\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":39,"alternative-id":["10.3389\/fneur.2025.1670436"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1670436","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"article-number":"1670436"}}